Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Romania's GDP recorded an increase in Q2 2025, according to flash estimates from the National Institute of Statistics (INS).
The Romgaz Group has reported a consolidated net profit of RON 1.67 billion (€338 million) for H1 2025 , which is 8.60% lower than the same period in 2024.
Romania's Minister of Finance Alexandru Nazare has announced changes to the tax regime of multinational firms as part of a wider effort to increase revenues to the budget.
JTI's global IT hub in Romania is expanding, with the number of employees growing from 140 at the beginning of the year to 170 currently, and projected to exceed 200 by year-end.
Digi Communications has reported consolidated revenues and other income of €1.11 billion for H1 2025, marking a 21% increase compared to the same period in 2024.